PCSK9 and Alzheimer disease: The most common PCSK9 LOF mutations in French Canadian individuals, InsLEU and R46L, did not have a protective or deleterious effect on AD prevalence or age of onset in French Canadian subjects (Reynolds et al., 2010; Paquette et al., 2018).